Two Sigma Securities’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,491
Closed -$7.46K 3671
2023
Q2
$7.46K Sell
10,491
-2,332
-18% -$2.09K ﹤0.01% 2630
2023
Q1
$15.5K Buy
12,823
+2,720
+27% +$2.87K ﹤0.01% 2398
2022
Q4
$8.38K Sell
10,103
-818
-7% -$914 ﹤0.01% 2386
2022
Q3
$15K Buy
+10,921
New +$24.6K ﹤0.01% 2342
2022
Q1
Sell
-649
Closed -$4K 2689
2021
Q4
$4K Sell
649
-1,965
-75% -$22.5K ﹤0.01% 1502
2021
Q3
$40K Buy
2,614
+1,450
+125% +$24.5K ﹤0.01% 1405
2021
Q2
$25K Sell
1,164
-597
-34% -$12.4K ﹤0.01% 1442
2021
Q1
$46K Buy
+1,761
New +$44.2K ﹤0.01% 741
2019
Q2
Sell
-52
Closed -$11K 2523
2019
Q1
$11K Buy
+52
New +$21K ﹤0.01% 1728

Other funds holding HSTO

Two Sigma Securities's HSTO Position: Q3 2023 in Review

Two Sigma Securities sold out of Histogen Inc. Common Stock (HSTO) in Q3 2023, closing a stake of 10,491 shares — an estimated $7.46K sold.

Two Sigma Securities first reported a position in HSTO in Q1 2019 and held it in 9 quarters. The position peaked at $46K in Q1 2021. 9 funds tracked by Wall St. Rank hold HSTO as of Q3 2023.

  • Two Sigma Securities reported no remaining Histogen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 10,491 Histogen Inc. Common Stock shares in Q3 2023, an estimated $7.46K.
  • Two Sigma Securities first reported a position in Histogen Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Two Sigma Securities's Histogen Inc. Common Stock position peaked at $46K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.